Search

Your search keyword '"Jilich, David"' showing total 8 results
Start Over Author "Jilich, David" Publisher elsevier bv
8 results on '"Jilich, David"'

1. The Presence of Both Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients From a Multinational Observational Study: Data From Euroguidelines in Central and Eastern Europe Network Group

Author

Kowalska, Justyna D., primary, Bieńkowski, Carlo, additional, Fleischhans, Lukáš, additional, Antoniak, Sergii, additional, Skrzat-Klapaczyńska, Agata, additional, Suchacz, Magdalena, additional, Bogdanic, Nikolina, additional, Gokengin, Deniz, additional, Oprea, Cristiana, additional, Karpov, Igor, additional, Kase, Kerstin, additional, Matulionyte, Raimonda, additional, Papadopoulus, Antonios, additional, Rukhadze, Nino, additional, Harxhi, Arjan, additional, Jilich, David, additional, Lakatos, Botond, additional, Sedlacek, Dalibor, additional, Dragovic, Gordana, additional, Vasylyev, Marta, additional, Verhaz, Antonija, additional, Yancheva, Nina, additional, Begovac, Josip, additional, and Horban, Andrzej, additional

Published
2022
Full Text
View/download PDF

2. The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease—A report from Central and Eastern Europe

Author

Kowalska, Justyna D., primary, Kase, Kerstin, additional, Vassilenko, Anna, additional, Harxhi, Arjan, additional, Lakatos, Botond, additional, Lukić, Gordana Dragović, additional, Verhaz, Antonija, additional, Yancheva, Nina, additional, Dumitrescu, Florentina, additional, Jilich, David, additional, Machala, Ladislav, additional, Skrzat-Klapaczyńska, Agata, additional, and Matulionyte, Raimonda, additional

Published
2021
Full Text
View/download PDF

3. FRI-247-Influence of HCV coinfection and HCV treatment on risk of diabetes mellitus in HIV infected persons

Author

Peters, Lars, primary, Lundgren, Jens D., additional, Rockstroh, Juergen, additional, Aho, Inka, additional, Wandeler, Gilles, additional, Edwards, Simon, additional, Lacombe, Karine, additional, Viard, Jean Paul, additional, Faetkenheuer, Gerd, additional, Guaraldi, Giovanni, additional, Laguno, Montserrat, additional, Llibre, Josep, additional, Elinav, Hila, additional, Nielsen, Lars, additional, Flamholc, Leo, additional, Gisinger, Martin, additional, Paduta, Dzmitry, additional, Khromova, Irina, additional, Jilich, David, additional, Rozptochowski, BtaZej, additional, Oprea, Cristiana, additional, and Mocroft, Amanda, additional

Published
2019
Full Text
View/download PDF

4. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial

Author

O'Connor, Jemma, Vjecha, Michael J, Phillips, Andrew N, Angus, Brian, Cooper, David, Grinsztejn, Beatriz, Lopardo, Gustavo, Das, Satyajit, Wood, Robin, Wilkin, Aimee, Klinker, Hartwig, Kantipong, Pacharee, Klingman, Karin L, Jilich, David, Herieka, Elbushra, Denning, Eileen, Abubakar, Ibrahim, Gordin, Fred, and Lundgren, Jens D

Subjects
Adult, Male, AIDS-Related Opportunistic Infections/epidemiology, Australia, HIV Infections/complications, Middle Aged, Viral Load, Drug Administration Schedule, CD4 Lymphocyte Count, Pneumonia, Bacterial/epidemiology, Antiretroviral Therapy, Highly Active/adverse effects, Tuberculosis/epidemiology, Anti-HIV Agents/adverse effects, Humans, Regression Analysis, Female, Bacterial Infections/epidemiology, Proportional Hazards Models
Abstract

BACKGROUND: The effects of antiretroviral therapy on risk of severe bacterial infections in people with high CD4 cell counts have not been well described. In this study, we aimed to quantify the effects of immediate versus deferred ART on the risk of severe bacterial infection in people with high CD4 cell counts in a preplanned analysis of the START trial.METHODS: The START trial was a randomised controlled trial in ART-naive HIV-positive patients with CD4 cell count of more than 500 cells per μL assigned to immediate ART or deferral until their CD4 cell counts were lower than 350 cells per μL. We used Cox proportional hazards regression to model time to severe bacterial infection, which was defined as a composite endpoint of bacterial pneumonia (confirmed by the endpoint review committee), pulmonary or extrapulmonary tuberculosis, or any bacterial infectious disorder of grade 4 severity, that required unscheduled hospital admissions, or caused death. This study is registered with ClinicalTrials.gov, number NCT00867048.FINDINGS: Patients were recruited from April 15, 2009, to Dec 23, 2013. The data cutoff for follow-up was May 26, 2015. Of 4685 HIV-positive people enrolled, 120 had severe bacterial infections (immediate-initiation group n=34, deferred-initiation group n=86; median 2·8 years of follow-up). Immediate ART was associated with a reduced risk of severe bacterial infection compared with deferred ART (hazard ratio [HR] 0·39, 95% CI 0·26-0·57, pINTERPRETATION: Immediate ART reduces the risk of several severe bacterial infections in HIV-positive people with high CD4 cell count. This is partly explained by ART-induced increases in CD4 cell count, but not by increases in neutrophil count.FUNDING: National Institute of Allergy and Infectious Diseases National Institutes of Health, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales, Bundesministerium für Bildung und Forschung, European AIDS Treatment Network, Australian National Health and Medical Research Council, UK National Institute for Health Research and Medical Research Council, Danish National Research Foundation.

Published
2017
Full Text
View/download PDF

5. HIV care in Central and Eastern Europe: How close are we to the target?

Author

Gokengin, Deniz, primary, Oprea, Cristiana, additional, Begovac, Josip, additional, Horban, Andrzej, additional, Zeka, Arzu Nazlı, additional, Sedlacek, Dalibor, additional, Allabergan, Bayjanov, additional, Almamedova, Esmira A., additional, Balayan, Tatevik, additional, Banhegyi, Denes, additional, Bukovinova, Pavlina, additional, Chkhartishvili, Nikoloz, additional, Damira, Alymbaeva, additional, Deva, Edona, additional, Elenkov, Ivaylo, additional, Gashi, Luljeta, additional, Gexha-Bunjaku, Dafina, additional, Hadciosmanovic, Vesna, additional, Harxhi, Arjan, additional, Holban, Tiberiu, additional, Jevtovic, Djorje, additional, Jilich, David, additional, Kowalska, Justyna, additional, Kuvatova, Djhamal, additional, Ladnaia, Natalya, additional, Mamatkulov, Adkhamjon, additional, Marjanovic, Aleksandra, additional, Nikolova, Maria, additional, Poljak, Mario, additional, Rüütel, Kristi, additional, Shunnar, Azzaden, additional, Stevanovic, Milena, additional, Trumova, Zhanna, additional, and Yurin, Oleg, additional

Published
2018
Full Text
View/download PDF

7. ID: 139

Author

Melkova, Zora, primary, Shankaran, Prakash, additional, Hajkova, Vera, additional, and Jilich, David, additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results